SCHEMBL9114837

SCHEMBL9114837

C[C@@]12CCC[C@H]1[C@@H]1C(C=O)C[C@H]3NC(=O)C=C[C@]3(C)[C@H]1CC2

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 6/20 0.43
SRD5A2 P31213 6/20 0.43
CYP19A1 P11511 3/20 0.36
LMNA P02545 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
ABCC4 O15439 1/20 0.36
ABCB11 O95342 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
CHRM1 P11229 1/20 0.36
HSD3B1 P14060 1/20 0.36
NFKB1 P19838 1/20 0.36
MAPK1 P28482 1/20 0.36
THPO P40225 1/20 0.36
BLM P54132 1/20 0.36
MBOAT4 Q96T53 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7901229 0.85 SRD5A1 (0.55) SRD5A1SRD5A2CYP19A1LMNACYP3A4
SCHEMBL7901226 0.85 SRD5A1 (0.55) SRD5A1SRD5A2CYP19A1LMNACYP3A4
SCHEMBL9134039 0.77 SRD5A1 (0.52) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL9134036 0.77 SRD5A1 (0.52) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL950330 0.76 SRD5A1 (0.53) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL950331 0.76 SRD5A1 (0.53) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL790657 0.76 SRD5A1 (0.53) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL7978401 0.74 SRD5A1 (0.38) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL7978400 0.74 SRD5A1 (0.38) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL9319615 0.72 SRD5A1 (0.37) SRD5A1SRD5A2LMNACYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0646007-A4 1995-04-26 EP disclosed
EP-0646007-A1 NEW DELTA-17 AND DELTA-20 OLEFINIC AND SATURATED 17-g(b)-SUBSTITUTED-4-AZA-5-g(a)-ANDROSTAN-3-ONES AS 5-g(a)-REDUCTASE INHIBITORS. MERCK & CO INC (US) 1995-04-05 EP disclosed